Chris Mason | Professor, Cell & Gene Therapy
University College London | United Kingdom

Chris Mason MD, PhD, FRSB, FRCS, FMedSci
Chris has over 30 years of cell and gene therapy experience spanning R&D, clinical medicine, manufacturing, and commercialization. He is a Full Professor of Cell & Gene Therapy at University College London. Chris is also a serial entrepreneur, including a Founder and Board Director of OriBiotech, and was a Founder and former CSO at Avrobio. He is on the Board of Directors of several cell and gene therapy companies and nonprofit organizations, including Krystal Biotech, Papillon Therapeutics, and The Foundation for mRNA Medicines. He is the Senior Editor of the journals, ‘Cell and Gene Therapy Insights’ and ‘Regenerative Medicine’. In 2019, Chris was elected as a Fellow of the Academy of Medical Sciences.